This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange fell a fraction to 591.12 Thursday. Emprise Capital Corp.'s NEX shell, Sixonine Ventures Corp., has closed its shell deal: It has launched a U.S. marijuana marketing and distribution company, Dionymed Brands Inc. (DYME: $3.49), on the Canadian Securities Exchange. Dionymed opened at $3.85 and closed at $3.49 on 221,500 shares.

Dionymed operates in California and Oregon. Its portfolio includes brands of dried flower, edibles, concentrates and vape cartridges, which are available at dispensaries as well as on-line (by home delivery). Dionymed expects to lose $2.75-million (U.S.) this year on a targeted revenue of just under $42-million (U.S.). Expected loss aside, the company managed to sell $7.16-million worth of shares at $4.25 to 84 investors in Canada earlier this month. Those 84 investors are likely disappointed with Dionymed's chart today, as the stock traded between $3.20 and $3.85.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS